Pharma Firm
-
{
- All
- News
- Videos
-
Weight Loss Injection For ₹900? Three Pharma Firms Launch Affordable Semaglutide, Check Prices
Indian pharmaceutical companies have launched affordable versions of semaglutide injections following a patent expiry, significantly lowering costs for diabetes and weight management treatment and improving access for millions of patients.
-
Indian Pharma Giants Launch Low-Cost Generic Semaglutide Injections For Diabetes, Weight Management
New Delhi, March 21 (IANS) Three Indian pharmaceutical companies have launched generic versions of semaglutide injections, after the drug’s patent expired, offering lower‑cost options for patients managing Type 2 diabetes and obesity.
-
India Cracks Down On Ads For Weight-Loss Drugs Like GLP-1 In New Advisory
India's Health Ministry has warned pharmaceutical firms against promoting GLP-1 weight-loss drugs to the public. The CDSCO says direct or indirect advertising, including influencer campaigns, violates drug laws and could attract regulatory action.
-
Weight-Loss Drugs Set To Get Cheaper In India As Semaglutide Patents Expire
The cost of popular weight-loss injections like Ozempic and Wegovy is expected to fall in India as patents on semaglutide expire in March 2026, paving the way for generic versions and wider access to anti-obesity medications.
-
'National Image Dented': Top Court Slams Pharma Firm Over Cough Syrup Deaths In Uzbekistan
"Do you realise what dent it has caused to the country's image?" the Supreme Court on Thursday asked a pharmaceutical firm whose cough syrups allegedly resulted in the death of more than 18 children in Uzbekistan.
-
"Kindly Relieve Me ASAP": Pharma Firm Finance Boss Quits Over Delhi Pollution
This resignation is seen as an unusual event in Indian corporate history, where an executive has cited environmental conditions as the reason for leaving.
-
Licence Of Tamil Nadu Firm Behind 'Killer' Cough Syrup Revoked
The Tamil Nadu Drug Control department has revoked the complete licence of Sresan Pharma, which manufactured 'Coldrif' cough syrup that led to the deaths of several children across India.
-
Coldrif Cough Syrup Deaths: Pharma Firm Owner Sent To 10-Day Police Custody
A Parasia court on Friday sent Sresan Pharma owner Ranganathan to 10-day police custody in connection with the deaths of children allegedly caused by the consumption of Coldrif cough syrup.
-
Operation Midnight: How Owner Of Pharma Firm Behind Syrup Tragedy Was Arrested
The pharmaceutical company owner, the key accused in the cough syrup tragedy that has claimed over a dozen children's lives in Madhya Pradesh, was arrested by the state police after a dramatic midnight operation.
-
Pharma Firm Owner Arrested Over 20 Children's Deaths Linked To Coldrif Syrup
The owner of the Tamil Nadu-based pharmaceuticals company that manufactured the adulterated Coldrif cough syrup linked to dozens of children's deaths in several states has been detained.
-
Weight Loss Injection For ₹900? Three Pharma Firms Launch Affordable Semaglutide, Check Prices
Indian pharmaceutical companies have launched affordable versions of semaglutide injections following a patent expiry, significantly lowering costs for diabetes and weight management treatment and improving access for millions of patients.
-
Indian Pharma Giants Launch Low-Cost Generic Semaglutide Injections For Diabetes, Weight Management
New Delhi, March 21 (IANS) Three Indian pharmaceutical companies have launched generic versions of semaglutide injections, after the drug’s patent expired, offering lower‑cost options for patients managing Type 2 diabetes and obesity.
-
India Cracks Down On Ads For Weight-Loss Drugs Like GLP-1 In New Advisory
India's Health Ministry has warned pharmaceutical firms against promoting GLP-1 weight-loss drugs to the public. The CDSCO says direct or indirect advertising, including influencer campaigns, violates drug laws and could attract regulatory action.
-
Weight-Loss Drugs Set To Get Cheaper In India As Semaglutide Patents Expire
The cost of popular weight-loss injections like Ozempic and Wegovy is expected to fall in India as patents on semaglutide expire in March 2026, paving the way for generic versions and wider access to anti-obesity medications.
-
'National Image Dented': Top Court Slams Pharma Firm Over Cough Syrup Deaths In Uzbekistan
"Do you realise what dent it has caused to the country's image?" the Supreme Court on Thursday asked a pharmaceutical firm whose cough syrups allegedly resulted in the death of more than 18 children in Uzbekistan.
-
"Kindly Relieve Me ASAP": Pharma Firm Finance Boss Quits Over Delhi Pollution
This resignation is seen as an unusual event in Indian corporate history, where an executive has cited environmental conditions as the reason for leaving.
-
Licence Of Tamil Nadu Firm Behind 'Killer' Cough Syrup Revoked
The Tamil Nadu Drug Control department has revoked the complete licence of Sresan Pharma, which manufactured 'Coldrif' cough syrup that led to the deaths of several children across India.
-
Coldrif Cough Syrup Deaths: Pharma Firm Owner Sent To 10-Day Police Custody
A Parasia court on Friday sent Sresan Pharma owner Ranganathan to 10-day police custody in connection with the deaths of children allegedly caused by the consumption of Coldrif cough syrup.
-
Operation Midnight: How Owner Of Pharma Firm Behind Syrup Tragedy Was Arrested
The pharmaceutical company owner, the key accused in the cough syrup tragedy that has claimed over a dozen children's lives in Madhya Pradesh, was arrested by the state police after a dramatic midnight operation.
-
Pharma Firm Owner Arrested Over 20 Children's Deaths Linked To Coldrif Syrup
The owner of the Tamil Nadu-based pharmaceuticals company that manufactured the adulterated Coldrif cough syrup linked to dozens of children's deaths in several states has been detained.
